Stock News•6 days ago
Why This Pharmaceutical Stock Jumped Close to 100% This Week
Shares of a pharmaceutical stock surged nearly 100% this week after agreeing to be acquired by a larger sector firm.
MarketLens
What's Behind Corcept's Recent Legal Troubles
4 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
What's Behind Paysafe's Latest Legal Headwinds
3 months ago
Category
You may also like
Stock News•1 week ago
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals (CRNX) faces an investigation into its $85/share sale to Vertex (VRTX), after a law firm alleged the board may have breached fiduciary duties by failing to conduct a fair pro...
Stock News•1 months ago
CORT Stock Rises 42% in a Month: Here's What You Should Know
Corcept shares rose 42% in a month, after relacorilant advanced in Cushing's syndrome and Lifyorli approval expanded the company's revenue base.
Stock News•1 months ago
U.S. District Court Issues Decision Regarding CINVANTI® Patents
Heron Therapeutics shares may face pressure after a U.S. District Court ruled two CINVANTI® patents invalid. The decision impacts U.S.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
Google Gemini Launch Delayed as Tech Falls Short of Internal Goals
Stock News•1 hour ago
Microsoft's Nadella rips Anthropic's Fable restrictions in staff meeting: 'Doesn't make sense'
Stock News•1 hour ago
Why QYLD's 11% Yield Quietly Erodes Your Wealth Every Month
Stock News•1 hour ago
Apple (AAPL) Rises As Market Takes a Dip: Key Facts
Stock News•1 hour ago